RNU6-287P

Across TCGA pan-cancer cohorts, RNU6-287P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-287P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNU6-287P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-287P expression acts as an unfavorable survival marker, although some lineages such as CHOL show a favorable association.

COAD, LUAD, and SARC are the cancer types where RNU6-287P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.163	0.692	<.001	135	view →
LUAD	OS	Tertile	All	0.223	0.835	<.001	72	view →
SARC	OS	Tertile	All	0.224	0.749	<.001	36	view →
SKCM	OS	Tertile	All	0.694	0.878	.006	21	view →
ESCA	OS	Quartile	II,III,IV	0.532	0.739	.009	18	view →
UVM	OS	Tertile	All	0.315	0.711	.049	9	view →
STAD	DFS	Quartile	All	0.574	0.740	.045	6	view →
CHOL	OS	Tertile	III,IV	1.000	0.361	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-287P–COAD (DFS)

Open the COAD breakdown →